American Century Companies Inc. Has $2 Million Position in Teleflex Incorporated (NYSE:TFX)

American Century Companies Inc. grew its stake in Teleflex Incorporated (NYSE:TFX) by 4.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,509 shares of the medical technology company’s stock after purchasing an additional 420 shares during the period. American Century Companies Inc.’s holdings in Teleflex were worth $2,000,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of TFX. Janus Henderson Group PLC raised its stake in shares of Teleflex by 12.0% during the first quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company’s stock worth $1,223,424,000 after buying an additional 581,312 shares during the last quarter. Cooke & Bieler LP grew its holdings in shares of Teleflex by 23.3% in the 2nd quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock valued at $191,989,000 after acquiring an additional 172,335 shares in the last quarter. Ceredex Value Advisors LLC bought a new position in shares of Teleflex in the second quarter valued at $25,550,000. National Bank of Canada FI lifted its stake in Teleflex by 1,008.2% in the 2nd quarter. National Bank of Canada FI now owns 115,343 shares of the medical technology company’s stock valued at $24,388,000 after purchasing an additional 104,935 shares during the last quarter. Finally, Vanguard Group Inc. increased its holdings in shares of Teleflex by 1.8% during the 1st quarter. Vanguard Group Inc. now owns 5,550,727 shares of the medical technology company’s stock worth $1,255,408,000 after acquiring an additional 96,711 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Insider Buying and Selling

In other news, Director Stuart A. Randle sold 2,674 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.82. Following the completion of the sale, the director now directly owns 5,496 shares of the company’s stock, valued at approximately $1,313,159.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.43% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on TFX. Royal Bank of Canada boosted their price target on Teleflex from $235.00 to $260.00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. Stephens increased their price objective on shares of Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Truist Financial increased their target price on shares of Teleflex from $240.00 to $247.00 and gave the stock a “hold” rating in a research note on Monday, August 5th. Finally, Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $205.00 to $245.00 in a report on Monday, July 1st. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, Teleflex presently has an average rating of “Moderate Buy” and an average price target of $265.57.

Teleflex Price Performance

Shares of TFX opened at $246.83 on Friday. Teleflex Incorporated has a fifty-two week low of $177.63 and a fifty-two week high of $257.85. The firm’s 50-day simple moving average is $237.48 and its two-hundred day simple moving average is $221.22. The stock has a market cap of $11.63 billion, a PE ratio of 39.62, a price-to-earnings-growth ratio of 2.23 and a beta of 1.16. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 2.58.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, topping analysts’ consensus estimates of $3.33 by $0.09. The business had revenue of $749.70 million during the quarter, compared to analyst estimates of $762.98 million. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. Teleflex’s revenue was up .9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.41 EPS. Analysts anticipate that Teleflex Incorporated will post 13.97 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Thursday, August 15th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.55%. The ex-dividend date of this dividend was Thursday, August 15th. Teleflex’s dividend payout ratio (DPR) is presently 21.83%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.